Disclosures for "Comprehensive Assessment of Immune-checkpoint Inhibitor (ICI)-induced Neurotoxicity (N-Tox) in Melanoma Patients"
-
Miss Dutt has or had stock in Esperion Therapeutics.Miss Dutt has or had stock in Iovance Biotherapeutics.Miss Dutt has or had stock in Moderna Therapeutics.Miss Dutt has or had stock in Regeneron Pharmaceuticals.
-
Dr. Kim has nothing to disclose.
-
Dr. Pan has nothing to disclose.
-
Mr. Qiu has nothing to disclose.
-
Dr. Onwumere has nothing to disclose.
-
Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for mSystems.
-
Dr. Osman has nothing to disclose.
-
Ms. Son has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen .